Immunic Inc
NASDAQ:IMUX

Watchlist Manager
Immunic Inc Logo
Immunic Inc
NASDAQ:IMUX
Watchlist
Price: 0.9361 USD 0.44% Market Closed
Market Cap: 89.7m USD

EV/OCF
Enterprise Value to OCF

-0.8
Current
-0.3
Median
5.7
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-0.8
=
Enterprise Value
70.1m USD
/
Operating Cash Flow
-82.6m USD
 
DE
Immunic Inc
NASDAQ:IMUX
Average EV/OCF: 20.2
Negative Multiple: -0.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -212 438.8
US
Abbvie Inc
NYSE:ABBV
23.9
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
Negative Multiple: -14 474
US
Amgen Inc
NASDAQ:AMGN
17.2
US
Gilead Sciences Inc
NASDAQ:GILD
14.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -117
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530
AU
CSL Ltd
ASX:CSL
31.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -83.2

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A